IZCFF yields 68965.52% · PFE yields 6.13%● Live data
📍 IZCFF pulled ahead of the other in Year 1
Combined, IZCFF + PFE cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of IZCFF + PFE for your $10,000?
International Zeolite Corp. explores for and develops mineral properties in Canada. It operates through two segments, Exploration and Development, and Retail and Commercial. The company markets and supplies natural zeolite and zeolite-infused products; and develops, markets, and sells industrial commercial products from the production of its properties, as well as supplies raw materials from third party suppliers. It also has interests in the Bromley Creek zeolite project, which consists of one mineral lease and four mineral claims covering approximately 1,134.75 hectares located near Princeton, British Columbia; and the Sun Group zeolite project covering approximately 948.935 hectares located in British Columbia. The company was formerly known as Canadian Zeolite Corp. and changed its name to International Zeolite Corp. in March 2018. International Zeolite Corp. was incorporated in 1987 and is headquartered in Vancouver, Canada.
Full IZCFF Calculator →Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Full PFE Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.